Public Health

In the third edition of Flair Russia, Ipsos experts share their vision of what the future may hold for us over the coming years and what signals of the future we can recognise today.

The success of a COVID-19 vaccine is one of the biggest challenges we face globally. This paper explores the opportunities and obstacles that lie ahead.

Our new 27-country survey finds rising levels of satisfaction and trust in health services as the world battles against the coronavirus pandemic. Waiting times and lack of staff are the main challenges perceived by the public.

Worldwide, more than 50 million people have contracted Covid-19. But the health cost to women goes far beyond the virus itself. AXA and Ipsos today reveal the results of a second study conducted among women on the impact of Covid-19.

Most adults across 15 countries don’t expect a vaccine to be available any sooner than mid-2021; only half would get vaccinated within three months of its availability.

COVID-19 has put the topic of vaccination centre-stage, with the expedited development of a COVID-19 vaccine viewed by many as the only real solution to the current pandemic – or at least part of it.

Challenges of patient engagement in an atopic dermatitis.

Huge numbers of cases and deaths, alongside conflicting messaging, have defined the country’s pandemic experience.

In recent years, the issue of mental health has risen up government and corporate agendas alike, reflecting the growing acknowledgement that mental health issues require the same level of understanding, treatment and advocacy as physical illness – and that we are all vulnerable. While there is still ground to conquer here, this momentum is gathering speed.